ARTICLE | Financial News
Sequoia China leads seed round for next-gen T cell therapy play
August 31, 2018 6:28 PM UTC
RootPath Inc. (Cambridge, Mass.) raised on Aug. 30 $7 million in a seed round led by Sequoia China. Fellow new investors Volcanics Venture, Baidu Ventures and Nest.Bio Ventures also participated.
Co-founder and CEO Xi Chen told BioCentury the funding provides a cash runway of 12-18 months...